Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.

Jones, S E; Grozea, P N; Metz, E N; Haut, A; Stephens, R L; Morrison, F S; Butler, J J; Byrne, G E; Moon, T E; Fisher, R; Haskins, C L; Coltman, C A

Jones, S E; Grozea, P N; Metz, E N; Haut, A; Stephens, R L; Morrison, F S; Butler, J J; Byrne, G E; Moon, T E; Fisher, R; Haskins, C L; Coltman, C A.

Cancer ; 43(2): 417-25, 1979 Feb.

Article in En | MEDLINE | ID: mdl-84706

Subject(s)

Antineoplastic Agents/administration & dosage; Doxorubicin/administration & dosage; Lymphoma/therapy; Antineoplastic Agents/adverse effects; BCG Vaccine/administration & dosage; Bleomycin/administration & dosage; Clinical Trials as Topic; Cyclophosphamide/administration & dosage; Drug Therapy, Combination; Humans; Prednisone/administration & dosage; Remission, Spontaneous; Time Factors; Vincristine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Lymphoma / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Year: 1979 Type: Article

Search on Google

XML

PubMed Links